considered and approved the unaudited standalone financial results of the Company for the quarter and half year ended September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Salem Erode Investments' board approved its unaudited standalone results for Q2 FY26 on November 13, 2025. Revenue from operations for the quarter fell sharply to ₹88.62 lakh from ₹120.44 lakh in Q2 FY25, a decline of roughly 26%. The company reported a net loss of ₹120.08 lakh for Q2 FY26, wider than the ₹84.64 lakh loss a year ago. For the half year, revenue declined to ₹197.50 lakh from ₹215.41 lakh, and the net loss stood at ₹219.05 lakh versus ₹214.98 lakh. Total expenses remained elevated at ₹213.52 lakh for the quarter, and operating cash flow stayed negative at ₹(421.02) lakh for H1 FY26. The statutory auditor Mohandas & Associates issued an unmodified (clean) limited review report on the results.
Shareholders should note that the company is still loss-making with shrinking top-line and continuing cash burn, though the auditor's report carries no qualifications. The widening quarterly loss and reduced equity base (other equity down to ₹1,605 lakh from ₹2,080 lakh) are negative signals for near-term stock sentiment.